Non-Aqueous Sample Preparation for Rapid Cytometry Sterility Testing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cytometry systems are unable to test non-aqueous pharmaceutical preparations due to filtration incompatibility, leading to reduced shelf-life and increased inventory hold times, and existing methods are time-consuming, affecting the accuracy and precision of sterility testing.
Innovation Solution
A method using isopropyl myristate (IPM) as a solvent to prepare non-aqueous samples for flow cytometry fluorescent detection, involving mixing, filtering, and presenting the sample on a membrane for analysis, which includes viability markers and laser interrogation to detect viable biological contaminants.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If cytometry systems are used to detect contaminant in pharmaceutical preparations, then detection sensitivity is improved (capable of detecting single living cell), but the method is limited to aqueous preparations only, excluding oil-based preparations
Solution Approach 1:
The patent introduces an intermediary aqueous buffer solution that facilitates the transfer of contaminant cells from the oil-based pharmaceutical preparation to the cytometry detection membrane. The buffer acts as a mediator that is compatible with both the oil-based sample and the aqueous cytometry system, enabling detection without direct contact between incompatible phases.
Solution Approach 2:
The patent changes the physical and chemical parameters of the sample preparation by using aqueous buffer solutions with specific pH levels and ionic compositions. This parameter adjustment allows the oil-based preparation to be processed through aqueous filtration and detection systems, expanding the applicability of cytometry to non-aqueous samples.
2Adaptability or versatility
If traditional culture-based sterility testing is performed on compounded pharmaceutical preparations, then the method is widely applicable to all preparation types, but the testing time is extended to 14-18 days, reducing productivity
Solution Approach 1:
The patent replaces the biological culture-based detection system with a physical cytometry detection system using laser interrogation and fluorescent markers. This substitution eliminates the need for prolonged incubation periods required for microbial growth, reducing testing time from 14-18 days to approximately 3 hours while maintaining detection capability.
Solution Approach 2:
The patent performs preliminary enrichment of contaminant cells during the filtration process itself, concentrating potential contaminants on the membrane before detection. This preliminary action eliminates the need for subsequent incubation periods required in traditional culture methods to allow microbial growth to detectable levels.
3Reliability
If USP sterility testing requirements are met for compounded pharmaceutical preparations, then compliance is ensured, but the labeled beyond use date is reduced to 4-6 days, increasing loss of time
Solution Approach 1:
The patent replaces traditional culture-based sterility testing with flow cytometry detection, enabling results to be obtained in approximately 3 hours rather than the 14-18 days required by conventional USP methods. This substitution maintains compliance with sterility testing requirements while dramatically reducing the time loss associated with prolonged testing periods.
Solution Approach 2:
The patent enables continuous monitoring and detection of viable contaminants throughout the shelf-life of compounded preparations. By using a rapid detection method that provides results in hours rather than days, the system allows for continuous quality assurance without interrupting the useful life of pharmaceutical preparations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid sterility testing of non-aqueous preparations within one day, maintaining accuracy and compliance with USP standards, reducing inventory hold times and financial losses.
Implementation Method 1
flow cytometry fluorescent detection system
Implementation Method 2
laser interrogation to detect viable biological contaminants
Data Source
Figure 1~2
Figure 3
AI summary
A method of preparing a sample for cytometry detection of viable biological contaminants includes obtaining a non-aqueous sample, obtaining a suitable solvent, and filtering the suitable solvent creating a filtered solvent. The non-aqueous sample is combined with the filtered solvent creating a mixture for cytometry testing.